Company performance
Add to research
Current Price
as of Jul 10, 2025$11.50
P/E Ratio
N/A
Market Cap
$1.87B
Description
Add to research
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017, and is headquartered in Radnor, PA.
Metrics
Add to research
Overview
- HQRadnor, PA
- SectorTechnology Services
- IndustryPackaged Software
- TickerCERT
- Price$11.5+0.26%
Trading Information
- Market cap$1.87B
- Float73.71%
- Average Daily Volume (1m)2,012,341
- Average Daily Volume (3m)1,949,892
- EPS-$0.02
Company
- Revenue$394.50M
- Rev growth (1yr)9.67%
- Net income$4.74M
- Gross margin47.65%
- EBITDA margin25.55%
- EBITDA$27.08M
- EV$1.73B
- EV/Revenue4.38
- P/EN/A
- P/S4.70
- P/B1.71
- Debt/Equity28.51
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset